Aberrant Collagen Cross-linking in Human Oral Squamous Cell Carcinoma

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Extracellular Matrix Research

Background:

• Tumor progression involves extracellular matrix (ECM) remodeling and stiffening.
• Mechanisms governing ECM changes and their role in tumor progression are not fully understood.
• Oral squamous cell carcinoma (OSCC) is a complex malignancy where ECM dynamics play a role.

Purpose of the Study:

• To investigate the association between collagen cross-linking and tumor stage in OSCC.
• To examine the role of key collagen cross-linking enzymes in OSCC progression and metastasis.
• To explore potential therapeutic strategies targeting collagen cross-linking in OSCC.

Main Methods:

• Bioinformatics analysis of gene expression.
• Immunohistochemical analysis of protein expression.
• Biochemical assays to quantify collagen cross-links.

Main Results:

• Genes for LH2, LOX, and LOXL2 are overexpressed in oral, head, and neck cancers.
• LH2, LOX, and LOXL2 are upregulated in late-stage OSCC and associated with poor prognosis.
• Increased protein levels of these enzymes and collagen cross-links are found in advanced tumors and lymph node-positive cases.

Conclusions:

• Collagen cross-linking, particularly LH2-mediated stable cross-links, is significantly increased in advanced OSCC.
• Upregulation of LH2, LOX, and LOXL2 is linked to OSCC progression and regional lymph node metastasis (RLNM).
• These findings highlight collagen cross-linking as a critical factor in OSCC and a potential therapeutic target.